FR2944446B1 - Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant - Google Patents
Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisantInfo
- Publication number
- FR2944446B1 FR2944446B1 FR0901825A FR0901825A FR2944446B1 FR 2944446 B1 FR2944446 B1 FR 2944446B1 FR 0901825 A FR0901825 A FR 0901825A FR 0901825 A FR0901825 A FR 0901825A FR 2944446 B1 FR2944446 B1 FR 2944446B1
- Authority
- FR
- France
- Prior art keywords
- soothing
- cosmetic
- pharmaceutical composition
- peptide hydrolyzate
- hydrolyzate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901825A FR2944446B1 (fr) | 2009-04-15 | 2009-04-15 | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901825A FR2944446B1 (fr) | 2009-04-15 | 2009-04-15 | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2944446A1 FR2944446A1 (fr) | 2010-10-22 |
FR2944446B1 true FR2944446B1 (fr) | 2013-08-16 |
Family
ID=40974605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0901825A Expired - Fee Related FR2944446B1 (fr) | 2009-04-15 | 2009-04-15 | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2944446B1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101384744B1 (ko) | 2011-05-23 | 2014-04-14 | 주식회사 인코스팜 | 보습능이 우수한 펩타이드 유도체 및 이의 용도 |
FR2990132B1 (fr) * | 2012-05-04 | 2014-06-06 | Cocagne & Cie | Extrait proteique de graine d'isatis tinctoria et compositions cosmetiques, dermatologiques ou pharmaceutiques le comprenant |
WO2016005243A1 (fr) | 2014-07-08 | 2016-01-14 | Henkel Ag & Co. Kgaa | Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de légumineuses de l'espèce pisum et/ou phaseolus et/ou vigna et/ou macrotyloma ou provenant de crucifères de l'espèce brassica, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2751161B2 (ja) * | 1986-10-13 | 1998-05-18 | 味の素株式会社 | 栄養組成物 |
TNSN02063A1 (en) * | 2001-07-07 | 2005-12-23 | Egyptian Natural Oil Co Natoil | The medical effect of jojoba oil |
FR2827174B1 (fr) * | 2001-07-13 | 2004-08-06 | Soc Extraction Principes Actif | Utilisation de peptides pour augmenter l'adhesion cellulaire |
DE10206353A1 (de) * | 2002-02-14 | 2003-08-28 | Cognis Deutschland Gmbh | Verwendung von niedermolekularen Proteinhydralysaten |
FR2869228B1 (fr) * | 2004-04-21 | 2008-09-05 | Vincience Sa | Utilisation d'un hydrolysat de proteines de cruciferes en tant qu'agent depigmentant dans ou pour une composition cosmetique et/ou pharmaceutique |
FR2925326B1 (fr) * | 2007-12-21 | 2010-02-26 | Vincience | Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines |
FR2925325B1 (fr) * | 2007-12-21 | 2010-02-26 | Vincience | Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines |
FR2925330B1 (fr) * | 2007-12-21 | 2010-04-09 | Vincience | Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines |
FR2925327A1 (fr) * | 2007-12-21 | 2009-06-26 | Vincience Sa | Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines |
-
2009
- 2009-04-15 FR FR0901825A patent/FR2944446B1/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2944446A1 (fr) | 2010-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2944526B1 (fr) | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere | |
EP2101745A4 (fr) | Administration de médicaments | |
IL209499A (en) | Human monoclonal antibody against influenza virus a, Pharmaceutical preparations containing it and its use in drug preparation | |
PL1976559T3 (pl) | Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy | |
DK2346495T4 (da) | Farmaceutisk formulering 514 | |
EP2186889A4 (fr) | Peptide cdca1 et agent pharmaceutique le comprenant | |
BRPI0821474A2 (pt) | formulação farmacêutica líquida estável | |
DK2029134T3 (da) | Stabiliserede farmaceutiske præparater omfattende fesoterodin | |
IL223455B (en) | Oral modified release pharmaceutical composition comprising immediate and delayed release febuxostat beads and use thereof | |
BRPI0807544A2 (pt) | Sólido farmacêutico e dose de vacina | |
BRPI0812575A2 (pt) | Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, sequência de nucleotídeos | |
BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
FR18C1032I2 (fr) | Anticorps anti-fgf23 et composition pharmaceutique le comprenant | |
FR2961814B1 (fr) | Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant. | |
FR2958157B1 (fr) | Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate | |
EP2519240A4 (fr) | Composition pharmaceutique comprenant de la metformine et de la rosuvastatine | |
EP2475649A4 (fr) | Dérivé d'indénone et composition pharmaceutique le comprenant | |
BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
BRPI1009823A2 (pt) | "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." | |
BRPI1008887A2 (pt) | peptídeos de foxm1 e vacinas contendo os mesmo | |
BRPI1009301A2 (pt) | peptídeos neil 3 e vacinas incluindo os mesmos | |
FR2958159B1 (fr) | Compostion cosmetique ou pharmaceutique | |
FR2949782B1 (fr) | Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant. | |
FR2944445B1 (fr) | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant | |
EP2322505A4 (fr) | Dérivé 1-adamantylazétidine-2-one et préparation pharmaceutique comprenant ce dérivé |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
ST | Notification of lapse |
Effective date: 20231205 |